Skip to content
Search

Latest Stories

Tata to construct India's new parliament building worth £90m

By Pramod Thomas

TATA-group company is all set to build India's new parliament building worth £90m, which will replace the existing colonial-era complex by 2022.


Tata Projects has won the bid to build the complex in the heart of the national capital, Delhi.

The country targets to open the new building when India celebrates 75 years of independence in two years.

Many object the move saying that the money should be spent on fighting Covid-19 in the country.

India reported another record jump in daily coronavirus infections with 97,894 cases in the last 24 hours, data from the health ministry showed on Thursday(17).

With 5.12 million cases in all, India is the world's second-worst affected country, and trails only the US, which has a caseload of around 6.6 million.

The country has also reported more than 80,000 deaths from the virus so far.

According to the Indian government, a new building is a necessity as the current one dates back to the 1920s and is 'over-used'.

Reports said that the proposed building will be larger than the current one, and will have seating for 1,400 MPs.

It will be a three-storey triangular structure, and is part of a $2.7bn government plan to modernise old colonial government buildings in Delhi.

The demand for a new parliament building dates back to nearly a decade with successive speakers of the parliament supporting the need for a new parliament building.

British architect Herbert Baker built the existing circular parliament building with a large domed hall and finished it in 1927.

Headquartered in Mumbai, Maharashtra, Tata Group is one of the biggest and oldest industrial groups in India, founded in 1868.

Each Tata company, including Tata Projects, operates independently under the guidance and supervision of its own board of directors and shareholders.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less